N-(2,6-Dimethylphenyl)chloroacetamide

We are N-(2,6-Dimethylphenyl)chloroacetamide CAS:1131-01-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:N-(2,6-Dimethylphenyl)chloroacetamide
CAS.NO:1131-01-7
Synonyms:N-(2,6-Dimethylphenyl)chloroacetamide
2-Chloro-n-(2,6-Dimethylphenyl)Acetamide
2-Chloro-2',6'-dimethylacetanilide
N-Chloroacetyl-2,6-dimethylaniline
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 316.8±30.0 °C at 760 mmHg
Melting Point 150-151 °C(lit.)
Molecular Formula C10H12ClNO
Molecular Weight 197.661
Flash Point 145.4±24.6 °C
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Ranolazine and Lidocaine.

N-(2,6-Dimethylphenyl)chloroacetamide


Related News: In order to seize the highest point of profits, international industry giants have adjusted their development strategies, concentrated their energies on the two ends of the smile curve-research and development and end products, and shifted production links such as intermediates and APIs outward. A division of labor model has been formed.Ácido 2-bromo-6-fluorobenzoico CAS:2252-37-1 In order to seize the highest point of profits, international industry giants have adjusted their development strategies, concentrated their energies on the two ends of the smile curve-research and development and end products, and shifted production links such as intermediates and APIs outward. A division of labor model has been formed.4-Amino-3-chlorophenol CAS:17609-80-2 In addition to APIs, a variety of pharmaceutical excipients are contained in the medicine.82294-70-0 In addition to APIs, a variety of pharmaceutical excipients are contained in the medicine.“With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.”

Related Products
Product Name
2-((2-Amino-4-nitrophenyl)amino)ethanol View Details
Decyl(trimethoxy)silane View Details
2-Amino-4,6-dimethoxypyrimidine View Details
1,3,5-TribroMo-2,4,6-TriMethyl-Benzene manufacturer 2,2′-Anhydro-5-methyluridine manufacturer 2-Amino-5-bromobenzoic acid manufacturer 5-((Z)-(5-Fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid manufacturer 10-bromobenzo[b]naphtho[1,2-d]furan manufacturer